Btai analyst ratings
WebApr 6, 2024 · Analyst Forecast According to 16 analysts, the average rating for BTAI stock is "Buy." The 12-month stock price forecast is $54.52, which is an increase of 215.51% from the latest price. WebApr 11, 2024 · BioXcel Therapeutics (NASDAQ:BTAI – Get Rating) last posted its …
Btai analyst ratings
Did you know?
WebBTAI will report Q1 earnings on 05/08/2024 Actual Analyst Range Consensus 1.00 0.00 -1.00 -2.00 More Overview Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only;... WebApr 11, 2024 · A number of equities analysts recently weighed in on BTAI shares. Mizuho lifted their price target on BioXcel Therapeutics from $24.00 to $38.00 and gave the stock a “buy” rating in a research ...
WebBTAI beat its sales estimates 0.00% of the time in past 12 months, while its overall … WebFeb 8, 2024 · The analyst revisited the BTAI model based on BXCL501 in schizophrenia, bipolar disorder, AD, and major depressive disorder (MDD), raising the peak sales estimate to $1.2 billion (vs. prior...
WebApr 10, 2024 · BioXcel Therapeutics, Inc. (NASDAQ:BTAI - Get Rating) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are covering the stock, MarketBeat.com reports.Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month … WebMar 20, 2024 · The number of analysts that have assigned BTAI a recommendation rating is 9. Out of them, 2 rate it a Hold, while 7 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged BioXcel Therapeutics Inc. (BTAI) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage …
WebOct 14, 2024 · BTAI 0.00% 73 See BTAI Report Wall Street is positive on BioXcel Therapeutics Inc ( BTAI ). On average, analysts give BioXcel Therapeutics Inc a Strong Buy rating. The average price target is $101.375, which means analysts expect the stock to climb by 251.51% over the next twelve months.
WebApr 10, 2024 · Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) have received an average rating of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat ... detoxing from opioids at homeWebApr 10, 2024 · BioXcel Therapeutics, Inc. ( NASDAQ:BTAI – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the stock, MarketBeat.com... church automotive testing californiaWebApr 12, 2024 · 7 analysts have issued 12 month target prices for BioXcel Therapeutics' … church autonomyWebApr 10, 2024 · Bioxcel Therapeutics (BTAI) In a report released today, Greg Harrison … church automotive testingWeb5 rows · See BioXcel Therapeutics, Inc. (BTAI) stock analyst estimates, including earnings and revenue, ... detoxing off of heroinWeb38 minutes ago · According to 6 analyst offering 12-month price targets in the last 3 months, Archer-Daniels Midland has an average price target of $90.83 with a high of $100.00 and a low of $85.00. church automotive sister bay wiWebApr 10, 2024 · Bioxcel Therapeutics (BTAI) In a report released today, Greg Harrison from Bank of America Securities reiterated a Buy rating on Bioxcel Therapeutics, with a price target of $43.00. The company ... church automotive tuning